BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 26056621)

  • 1. Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy.
    Wang N; Bu R; Duan Z; Zhang X; Chen P; Li Z; Wu J; Cai G; Chen X
    PeerJ; 2015; 3():e990. PubMed ID: 26056621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Exosomal MicroRNAs as New Noninvasive Biomarkers of IgA Nephropathy.
    Li S; Hao H; Li R; Guo S
    Tohoku J Exp Med; 2022 Mar; 256(3):215-223. PubMed ID: 35314529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma microRNA signature of patients with IgA nephropathy.
    Wu J; Zhang H; Wang W; Zhu M; Qi LW; Wang T; Cheng W; Zhu J; Shan X; Huang Z; Zhang L; Chen Y; Sun B; Zhao X; Qian J; Zhu W; Zhou X; Xing C
    Gene; 2018 Apr; 649():80-86. PubMed ID: 29459010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
    Min QH; Chen XM; Zou YQ; Zhang J; Li J; Wang Y; Li SQ; Gao QF; Sun F; Liu J; Xu YM; Lin J; Huang LF; Huang B; Wang XZ
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28383146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression.
    Jiang WL; Peng YM; Liu YH; Liu H; Chen GC; Xu XQ; Zhu XJ; Liu FY
    Ren Fail; 2012; 34(7):821-6. PubMed ID: 22679920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy.
    Yoon SY; Kim JS; Jung SW; Kim YG; Hwang HS; Moon JY; Lee SH; Seo JW; Seok J; Tae D; Jeong K
    Sci Rep; 2023 Oct; 13(1):17201. PubMed ID: 37821628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy.
    Duan ZY; Cai GY; Bu R; Lu Y; Hou K; Chen XM
    Sci Rep; 2016 Mar; 6():23498. PubMed ID: 27000966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy.
    Zhang M; Duan ZY; Zhang QY; Xu XG; Zhang Y; Wang P; Duan SW; Wu J; Chen XM; Cai GY
    Sci Rep; 2023 Apr; 13(1):6048. PubMed ID: 37055445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Liang S; Cai GY; Duan ZY; Liu SW; Wu J; Lv Y; Hou K; Li ZX; Zhang XG; Chen XM
    BMC Nephrol; 2017 Feb; 18(1):63. PubMed ID: 28201996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-100-3p and miR-877-3p regulate overproduction of IL-8 and IL-1β in mesangial cells activated by secretory IgA from IgA nephropathy patients.
    Liang Y; Zhao G; Tang L; Zhang J; Li T; Liu Z
    Exp Cell Res; 2016 Oct; 347(2):312-21. PubMed ID: 27542871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy.
    Duan ZY; Bu R; Liang S; Chen XZ; Zhang C; Zhang QY; Li JJ; Chen XM; Cai GY
    Front Immunol; 2024; 15():1326026. PubMed ID: 38426107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of microRNA-33a-5p in serum, urine and renal tissue of patients with IgA nephropathy.
    Liu L; Duan A; Guo Q; Sun G; Cui W; Lu X; Yu H; Luo P
    Exp Ther Med; 2021 Mar; 21(3):205. PubMed ID: 33500698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
    BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both Peripheral Blood and Urinary miR-195-5p, miR-192-3p, miR-328-5p and Their Target Genes PPM1A, RAB1A and BRSK1 May Be Potential Biomarkers for Membranous Nephropathy.
    Zhou G; Zhang X; Wang W; Zhang W; Wang H; Xin G
    Med Sci Monit; 2019 Mar; 25():1903-1916. PubMed ID: 30865617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy.
    Wang G; Kwan BC; Lai FM; Chow KM; Kam-Tao Li P; Szeto CC
    Dis Markers; 2010; 28(2):79-86. PubMed ID: 20364043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Value of Urinary miR-152-5p in Patients with IgA Nephropathy with Elevated Proteinuria Levels.
    Duan A; Liu L; Lou Y; Zhang D; Li H; Chen Y; Cui W; Miao L
    Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy.
    Hennino MF; Buob D; Van der Hauwaert C; Gnemmi V; Jomaa Z; Pottier N; Savary G; Drumez E; Noël C; Cauffiez C; Glowacki F
    Sci Rep; 2016 Jun; 6():27209. PubMed ID: 27264483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The increased miRNA-150-5p expression of the tonsil tissue in patients with IgA nephropathy may be related to the pathogenesis of disease.
    Xu Y; He Y; Hu H; Xu R; Liao Y; Dong X; Song H; Chen X; Chen J
    Int Immunopharmacol; 2021 Nov; 100():108124. PubMed ID: 34600394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating MiR-29a, Possible Use as a Biomarker for Monitoring IgA Nephropathy.
    Hu H; Wan Q; Li T; Qi D; Dong X; Xu Y; Chen H; Liu H; Huang H; Wei C; Zhou W; Jiang S; Mo Z; Liao F; Xu Q; He Y
    Iran J Kidney Dis; 2020 Mar; 14(2):107-118. PubMed ID: 32165595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of microRNA miR-150-5p in IgA nephropathy as a potential mediator and marker of disease progression.
    Pawluczyk IZA; Didangelos A; Barbour SJ; Er L; Becker JU; Martin R; Taylor S; Bhachu JS; Lyons EG; Jenkins RH; Fraser D; Molyneux K; Perales-Patón J; Saez-Rodriguez J; Barratt J
    Kidney Int; 2021 May; 99(5):1127-1139. PubMed ID: 33417998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.